Teniposide Solution For Injection 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Teniposide: Solution for injection (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

TENIPOSIDE (ten i POE side) is a chemotherapy drug. This medicine slows cancer cell growth. It is used to treat acute lymphocytic leukemia.

Similar Brand Name Drugs : Vumon: Solution for injection (10mg)
In-Depth Information

Teniposide 50mg/5ml Solution for Injection

NDC: 445670507
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Acute Lymphocytic Leukemia (ALL)

Sometimes used for but not FDA approved for the following conditions:
Small Cell Lung Cancer (SCLC), Non-Hodgkin's Lymphoma (NHL), Neuroblastoma, Non-small Cell Lung Cancer (NSCLC), Bladder Cancer

Storage Information
Refrigerate (between 36 and 46 degrees F)
Store in original package until time of use
Protect from light
Teniposide 50mg/5ml Solution for Injection

Reported Side Effects for Teniposide 50mg/5ml Solution for Injection

Chills Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Breathing Difficulties Incidence:
<5.0%*
Severity: SEVERE
Onset: RAPID
Anaphylactoid Reactions Incidence:
<5.0%*
Severity: SEVERE
Onset: RAPID
Confusion Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Flushing Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Hives Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Rapid Heart Rate Incidence:
<5.0%*
Severity: MODERATE
Onset: RAPID
High Blood Pressure Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Low Blood Pressure Incidence:
2.0%*
Severity: MODERATE
Onset: RAPID
Skin Rash Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Bleeding Incidence:
5.0%*
Severity: MODERATE
Onset: EARLY
Hair Loss Incidence:
9.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
12.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
29.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
29.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
33.0%*
Severity: MILD
Onset: EARLY
Mouth Ulcers Incidence:
>76.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
85.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
88.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
89.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
95.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Teniposide

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5